Sir,

A 15-year-old female patient presented with intermittent pain over ulcerated lesion on the frontoparietal region of the scalp. She was fine until 6 months back when she started developing multiple ulcers over the frontoparietal area which coalesced to the present size of about 4 cm × 3 cm \[[Figure 1](#F1){ref-type="fig"}\] with pus-like discharge. She had a history of burn in childhood followed by scarring of the area. An excisional biopsy was performed. Histopathological sections showed tumor comprising of atypical squamous epithelial cells arranged in nests, sheets, and clusters with invasion of subepithelial tissue with abnormal keratinization \[[Figure 2a](#F2){ref-type="fig"}\]. Numerous keratin pearls and extensive areas of necrosis were seen. Tumor cells were highly pleomorphic with bizarre and atypical mitotic figures \[[Figure 2b](#F2){ref-type="fig"}\]. A differential diagnosis of squamous cell carcinoma (SCC) and malignant proliferating trichilemmal tumor (MPTT) was considered, and immunohistochemistry (IHC) for calretinin, CD34, Ki67, CK15, and p53 was advised. IHC revealed strong p53 staining \[[Figure 3a](#F3){ref-type="fig"}\] and Ki67 labeling index of 40% \[[Figure 3b](#F3){ref-type="fig"}\]; however, calretinin and CD34 came out to be negative, ruling out trichilemmal differentiation and confirming a final diagnosis of SCC.

![Ulcerated lesion in the frontoparietal region of the scalp](IJD-64-339b-g001){#F1}

![Histopathology (a) atypical squamous epithelial cells arranged in nests, sheets, and clusters with abrupt keratinization (H and E, ×100) (b) Highly pleomorphic individual tumor cells with bizarre and atypical mitotic figures (H and E, ×400)](IJD-64-339b-g002){#F2}

![Immunohistochemistry (a) p53 positive (×200), (b) ki67 positive (×200)](IJD-64-339b-g003){#F3}

Proliferating trichilemmal tumor (PTT) is a rare benign neoplasm arising from the isthmus region of the outer root sheath of the hair follicle, comprising of only 0.1% of skin biopsies; however, MPTT is even rarer.\[[@ref1]\] It occurs most commonly in elderly female, predominantly on the scalp region. Long-standing burn scars have a high potential for malignant degeneration mainly in the lower and upper extremities (60%) followed by presternal region and rarely in the scalp region or other parts of the body and are seen more commonly in males.\[[@ref1]\] Burn scar carcinomas of the scalp account for 14% of burn scar carcinomas.\[[@ref2]\] The average latent period for appearance of SCC is 35 years.\[[@ref3]\] The present case is a case of SCC in a young female developing over a burn scar in the scalp region with a latent period of about 10 years.

The histological hallmark of PTT is the presence of abrupt trichilemmal keratinization -- the sudden transition of a nucleated epithelial cell to an anucleated, amorphous, compact keratinized cell that covers the cyst wall without the formation of granular layer.\[[@ref4][@ref5]\] The present case showed abrupt keratinization along with the presence of squamous cell differentiation thereby creating a dilemma.

IHC plays an important role in differentiating the two entities. On extensive review of literature,\[[@ref4][@ref5][@ref6][@ref7]\] as elaborated in [Table 1](#T1){ref-type="table"}, it was found that CD34 and calretinin are two important immunohistochemical markers of outer root sheath differentiation, showing positivity in PTT. Proliferation markers such as Ki67 and p53 staining were high in both SCC and malignant PTT. Most PTT showed positive staining for AE13 and AE14, while SCC showed no staining. In the present case, calretinin and CD34 came out to be negative, ruling out trichilemmal differentiation. Cutaneous SCC is treated with surgical excision including Mohs micrographic surgery, with radiotherapy being given in cases of incomplete resection.

###### 

Details of different immunohistochemical markers in proliferating trichilemmal tumor/squamous cell carcinoma in various studies in the literature

  Years        Authors                                                                                                           Number of cases of MPTT/SCC                                  IHC markers studied   Results and Conclusion
  ------------ ----------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------ --------------------- ------------------------------------------------------------------------------------------
  2010         Chaichamnan *et al*.\[[@ref4]\]                                                                                   MPTT - 2 cases, PTT - 3 cases, TC - 3 cases, SCC - 3 cases   p53                   MPTT both cases showed variable expression pattern of CD34
  CD34         Ki67 positivity showed a significantly increase in both MPTT and three cases of SCC                                                                                                                  
  ki67         TC and PTT showed only focal nuclear staining of basal cells                                                                                                                                         
               Immunoreactivity for p53 was detected in all cases of MPTT and SCC in strongly diffuse nuclear staining pattern                                                                                      
  2011         Gulati *et al*.\[[@ref5]\]                                                                                        MPTT - 1 case in a 65-year-old female                        CD34                  Membrane positivity for CD34 in \>70%
  Calretinin   Calretinin - positive                                                                                                                                                                                
  ki67         Ki67 immunostaining - only 20%                                                                                                                                                                       
  P53          p53 - strong diffuse nuclear                                                                                                                                                                         
  2013         Rangel-Gamboa *et al*.\[[@ref6]\]                                                                                 Pilar tumors - 12 cases                                      ki67                  Nine cases, ki67 immunostaining was observed in the basal cells of the cystic epithelium
               One case was moderately positive in palisading epithelial cells                                                                                                                                      
               Other two cases, ki67 immunostaining was negative                                                                                                                                                    
  2015         Alici *et al*.\[[@ref7]\]                                                                                         MPTT - 1 case in a 52-year-old female                        CD34                  40% membranous staining with CD34
  ki67         Ki67 proliferation index: 20%                                                                                                                                                                        
  p53          P53 staining was strongly positive in 80% of the cells                                                                                                                                               

PTT: Proliferating trichilemmal tumor, MPTT: Malignant proliferating trichilemmal tumor, SCC: Squamous cell carcinoma, IHC: Immunohistochemistry, TC: Trichilemmal cyst

The present study highlights the importance of histomorphological features along with IHC to prevent the misdiagnosis of PTT and avoid mistreatment.
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